Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R DeBenedetto

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Journal of Ocular Pharmacology|January 1, 1994
Functional evidence for retinal adenosine receptorsC E Crosson, R DeBenedetto, J M Gidday
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2018
Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trialM Gross-Goupil, T G Kwon, M Eto, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Journal of Ocular Pharmacology|January 1, 1994
Functional evidence for retinal adenosine receptorsC E Crosson, R DeBenedetto, J M Gidday
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2018
Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trialM Gross-Goupil, T G Kwon, M Eto, et al.
Pageof 1